Trial Profile
A Single Center Study to Evaluate the Efficacy and Safety of Rituximab in Patients with Refractory Auto-immune Hepatitis (AIH)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune hepatitis
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record